Ossio has raised $22 million following an FDA clearance for its bio-integrative bone pin system that aims to replace more-permanent metal implants.
The FDA acknowledged an growing number of reports linked to surgical staplers and plans to re-evaluate whether they should undergo premarket review.
Novo Nordisk has partnered with Taiwan-based Health2Sync to help promote the latter’s digital diabetes management app in Japan.
Former Medtronic Diabetes chief medical officer Francine Kaufman has joined continuous glucose monitor developer Senseonics as its new CMO.
Saranas got a de novo clearance from the FDA for its Early Bird system, used to detect internal bleeding in real time during endovascular procedures.
Israeli venture investor OurCrowd has launched a new $50 million fund, and it's the first to be focused exclusively on medtech and healthcare delivery.
Akili Interactive is teaming up with Osaka-based Shionogi to help bring the first prescription digital therapeutics to Japan and Taiwan.
Digital pathology startup Paige.AI has received a breakthrough device designation from the FDA for its use of AI in the diagnosis of cancer.
2014 Fierce 15 company Gynesonics unveiled data spanning more than five years, tracking its ablation treatment for uterine fibroids.
Glooko’s mobile app is now free for any person with diabetes, with the company ditching subscription fees for unsponsored users.